The study, published in The Lancet, examined the clinical characteristics of critically ill COVID-19 patients admitted to two NewYork-Presbyterian hospitals affiliated with Columbia University Irving Medical Center in New York City from March 2 to April 1. Of the 1,150 COVID-19 patients admitted to both hospitals, 257 (22 percent) were critically ill.
Five study findings:
1. The median age of the critically ill patients was 62 years.
2. Sixty-seven percent were men.
2. Eighty-two percent of the patients had at least one chronic illness — most commonly hypertension (63 percent) and diabetes (36 percent).
3. About 46 percent were obese.
4. Seventy-nine percent of the patients received invasive mechanical ventilation for a median of 18 days.
5. The researchers conducted a follow-up April 28, and found 39 percent of the patients had died and 37 percent remained hospitalized.
More articles on patient safety & outcomes:
COVID-19 nearly triples death risk of cancer patients, study finds
6 insights into COVID-19 patient care patterns worldwide
COVID-19 is 13 times deadlier than flu, study suggests
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
